课题基金 / 基金详情

Novel Targets that Modulate Multiple Adult Models of ALS in Drosophila

Novel Targets that Modulate Multiple Adult Models of ALS in Drosophila
调节果蝇多种 ALS 成人模型的新靶点
批准号:
10286166
负责人:
SPYRIDON ARTAVANIS-TSAKONAS
金额:
$46.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2022-12-31
关键词:
ALS pathologyALS patientsAddressAdultAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyotrophic Lateral SclerosisAttentionAxonBiological MarkersBiological ModelsBiologyBrainC9ORF72CatalysisCellsChronicClinicalCollectionComplexDNA Sequence AlterationDNA-Binding ProteinsDataDevelopmentDiseaseDisease modelDrosophila genusFailureFunding MechanismsFutureGenesGeneticGenetic DiseasesGenetic EpistasisGrowth FactorHumanInduced MutationKDR geneLettersLinkLongevityMalignant NeoplasmsMembraneModelingMolecularMolecular GeneticsMotorMotor ActivityMotor NeuronsMuscle WeaknessMuscular AtrophyMutationNerve DegenerationNervous system structureNeurodegenerative DisordersNeurogliaNeuromuscular JunctionOnset of illnessOutcomeOutputPDGF Signaling PathwayParkinson DiseasePathway interactionsPharmacologyPhenotypePhospholipase DPlatelet-Derived Growth FactorProtein Kinase CPublishingRespiratory FailureSeverity of illnessSignal PathwaySignal TransductionSiteSpecificitySpinal CordSpinal Muscular AtrophySynapsesSystemTestingTherapeuticTherapeutic InterventionTimeTissuesTransactVascular Endothelial Growth Factorsbasecell typedisease phenotypeeffective therapyfamilial amyotrophic lateral sclerosisfused in sarcomagenetic analysisgenetic architecturegenome wide association studyin vivoin vivo Modelinduced pluripotent stem cellinhibitor/antagonistkinase inhibitornetwork architectureneuromuscularneuron lossneuroprotectionnovelnovel therapeutic interventionnovel therapeuticspreventreceptorresponsesmall molecule inhibitorsporadic amyotrophic lateral sclerosistherapeutic targettooltrafficking

项目摘要

项目成果

SPYRIDON ARTAVANIS-TSAKONAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a catastrophic neurodegenerative disorder that selectively involves motor neurons in the brain and spinal cord, resulting in progressive muscle weakness and atrophy. It is estimated to affect 2/10000 people, is invariably lethal within 3-5 years, and completely lacks therapeutic treatments. The underlying biology and molecular mechanisms leading to the disease are not well understood. More than 90% of the cases are of unknown genetic origin (sporadic ALS). Genome-wide association studies have identified more than twenty different genes associated with familial ALS (10% of total cases), indicating a complex underlying genetic architecture. Given the paucity of therapeutic interventions there is a great unmet need to develop novel therapies. A key to this is a better molecular and genetic understanding of the causes underlying ALS phenotypes. Through parallel genetic disease model screens in Drosophila, we found that mutations in phospho-lipase D (PLD), and at least six components in its upstream intracellular pathway, serve to suppress and control the toxic impact of TDP-43 and FUS mutations in the nervous system, indicating that the PLD pathway is a significant potential ALS target. This signaling pathway is multifunctional and has been linked to cancer as well as other neurodegenerative diseases. We also identified the VEGF/PDGF growth factor pathway (Pvf-Pvr in Drosophila), a likely upstream signaling input to PLD, as an potent modulator of ALS phenotypes. Deeper analysis to understand the specific mechanisms underlying the impact of PLD and VEGF/PDGF on ALS phenotypes is essential before they can be pursued as future therapeutic targets. Here, we propose to further leverage the strengths of Drosophila to confirm that changes in the PLD pathway modulation can prevent progressive, adult-onset neuromuscular failure. Depending on the results we will obtain, this exploratory project (R21) may form the basis to justify future analysis under R01-based mechanism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein complex inter-connections in Drosophila
  • 批准号:
    8633470
  • 项目类别:
  • 资助金额:
    $21.19万
  • 财政年份:
    2013
  • 负责人:
    SPYRIDON ARTAVANIS-TSAKONAS
  • 依托单位:
Protein complex inter-connections in Drosophila
  • 批准号:
    8426727
  • 项目类别:
  • 资助金额:
    $25.4万
  • 财政年份:
    2013
  • 负责人:
    SPYRIDON ARTAVANIS-TSAKONAS
  • 依托单位:
Genetic Modeling for SMA Therapeutic Pathways
  • 批准号:
    8109335
  • 项目类别:
  • 资助金额:
    $134.2万
  • 财政年份:
    2010
  • 负责人:
    SPYRIDON ARTAVANIS-TSAKONAS
  • 依托单位:
Genetic Modeling for SMA Therapeutic Pathways
  • 批准号:
    7991536
  • 项目类别:
  • 资助金额:
    $140.15万
  • 财政年份:
    2010
  • 负责人:
    SPYRIDON ARTAVANIS-TSAKONAS
  • 依托单位:
海外基金